Literature DB >> 14827066

Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

C H MILLIKAN, L M EATON.   

Abstract

Entities:  

Keywords:  ACTH; CORTISONE; MYASTHENIA GRAVIS

Mesh:

Substances:

Year:  1951        PMID: 14827066     DOI: 10.1212/wnl.1.3.145

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

Review 1.  [ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

2.  [Clinical aspects of myopathy].

Authors:  H BECKER
Journal:  Dtsch Z Nervenheilkd       Date:  1955

3.  [Chemotherapy of myasthenia].

Authors:  H BAUER; O SCHMID
Journal:  Dtsch Z Nervenheilkd       Date:  1953

Review 4.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 6.  Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Authors:  Itay Lotan; Mark A Hellmann; Adi Wilf-Yarkoni; Israel Steiner
Journal:  J Neurol       Date:  2020-10-16       Impact factor: 6.682

7.  Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.

Authors:  C A Cape; R A Utterback
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

8.  Treatment of ocular myasthenia with corticotrophin.

Authors:  F B Gibberd; F Navab; C L Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

9.  Corticotropin and cortisone in diseases of the nervous system.

Authors:  H H MERRITT
Journal:  Yale J Biol Med       Date:  1952-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.